Ed Yunis
About Ed Yunis
Ed Yunis serves as the Director of Global Supply Chain & Procurement at AmplifyBio, having previously held key supply chain roles at Pfizer, iBio, and Sanofi. With a strong background in industrial engineering and extensive experience in managing supply chains for biopharmaceuticals, he has collaborated with various regulatory bodies and led significant projects across multiple departments.
Current Role at AmplifyBio
Ed Yunis serves as the Director of Global Supply Chain & Procurement at AmplifyBio, a position he has held since 2023. His role is based in New Albany, Ohio, and operates in a hybrid work environment. In this capacity, he is responsible for overseeing the supply chain operations and procurement strategies that support the company's objectives in the biotechnology sector.
Previous Experience at Pfizer
Before joining AmplifyBio, Ed Yunis worked at Pfizer as the Global Supply Chain Market Lead from 2016 to 2021. During his five years at Pfizer, he contributed to the management of supply chain processes and strategies, enhancing the company's operational efficiency in the pharmaceutical industry.
Professional Background in Supply Chain Management
Ed Yunis has extensive experience in supply chain management, having held various leadership roles. He was the Director of Global Supply Chain & Procurement at iBio, Inc. from 2021 to 2023, and prior to that, he served as Supply Chain Director at Sanofi in Saudi Arabia for one year. His career also includes significant positions at Cigalah Group, where he was Director of Operations and Head of Supply Chain & Procurement.
Educational Qualifications
Ed Yunis holds a Bachelor's degree in Industrial Engineering from the University of Applied Science and Technology, which he completed from 1992 to 1997. He furthered his education by earning a Master's degree in Engineering/Industrial Management from The Ohio State University in 2003.
Expertise in Supply Chain Operations
Ed Yunis has demonstrated expertise in various aspects of supply chain operations, including procurement compliance, negotiation, and logistics. He has supported the manufacture and supply of therapies such as monoclonal antibodies and cell/gene therapies. His experience includes collaborating with regulatory bodies and managing supply contracts with contract manufacturers.